Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeutics

International Journal of Pharmaceutics

Volumn 453, Issue 2, 2013, Pages 610-619

  Xu, Xiaofen ^a   Li, Yanggong ^a   Wang, Feihu ^a   Lv, Li ^a   Liu, Jieying ^a   Li, Mingna ^a   Guo, Aijie ^a   Jiang, Jinjun ^a   Shen, Yuanyuan ^a   Guo, Shengrong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cellular uptake; Cytotoxicity; In vivo anti tumor activity; NCTD HACC

Indexed keywords

AMMONIUM CHLORIDE; CHITOSAN DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; NORCANTHARIDIN; NORCANTHARIDIN CONJUGATED HYDROXYPROPYLTRIMETHYL AMMONIUM CHLORIDE CHITOSAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; KUNMING MOUSE; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; X RAY DIFFRACTION;

EID: 84884152873     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.05.052     Document Type: Article

References (31)

1. Benlloch, M., Mena, S., Ferrer, P., Obrador, E., Asensi, M., Pellice r, J.A., 2006. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and glutamine-enriched diet facilitate elimination of highly resistant B16 elanoma cells by tumor necrosis factor-alpha and chemotherapy. J. Biol. Chem. 281, 69-79. (Pubitemid 43671164)
2. Chen, Y.N., Cheng, C.C., Chen, J.C., Tsauer, W., Hsu, S.L., 2003. Norcantharidin induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br. J. Pharmacol. 140, 461-470. (Pubitemid 37330490)
3. Chen, Y.J., Kuo, C.D., Tsai, Y.M., Yu, C.C., Wang, G.S., Liao, H.F., 2008. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells. Anti-Cancer Drug. 19, 55-64.
4. Chen, Y.J., Chang, W.M., Liu, Y.W., Lee, C.Y., Jang, Y.H., Kuo, C.D., Liao, H.F., 2009. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells. Chem. Biol. Interact. 181, 440-446.
5. Chavanpatil, M.D., Ayman, K., Jayanth, P., 2006. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J. Nanosci. Nanotechnol. 6, 2651-2663. (Pubitemid 44579937)
6. Duncan, R., 2003. The drawing era of polymer therapeutics. Nat. Rev. Drug. Discov. 2, 347-360.
7. Duncan, R., 2007. Designing polymer conjugates as lysosomotropic nanomedicines. Biochem. Soc. Trans. 35, 56-60.
8. Fan, Y.Z., Fu, J.Y., Zhao, Z.M., Chen, C.Q., 2005. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. World. J. Gastroenterol. 11, 2431-2437.
9. Guan, M., Zhou, Y., Zhu, Q.L., Liu, Y., Bei, Y.Y., Zhang, X.N., Zhang, Q., 2012. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy. Nanomedicine 8, 1172-1181.
10. Grayson, S.M., Godbey, W.T., 2008. The role of macromolecular architecture in passively targeted polymeric carriers for drug and gene delivery. J. Drug Target 16, 329-356. (Pubitemid 351940516)
11. Hong, M.H., Zhu, S.J., Jiang, Y.Y., Tang, G.T., Sun, C., Fang, C., Shi, B., Pei, Y.Y., 2010. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. J. Control. Release 141, 22-29.
12. Hong, W.W., Zhang, Y.X., Lv, P.T., Zhou, X.Y., Shi, L., Deng, Y.H., 2009. Synthesis and antitumor activity of norcantharidin chitosan derivative. Chin. J. Pharm. 7, 171-176.
13. Han, H.D., Lee, A., Hwang, T., Song, C.K., Seong, H., Hyun, J., Shin, B.C., 2007. Enhanced circulation time and antitumor activity of doxorubicin by comb like polymer-incorporated liposomes. J. Control. Release 120, 161-168. (Pubitemid 47058634)
14. Kamiyama, K., Onishi, H., Machida, Y., 1999. Biodisposition characteristics of N-succinyl-chitosan and glycol-chitosan in normal and tumor-bearing mice. Biol. Pharm. Bull. 22, 179-186. (Pubitemid 29114036)
15. Kakizawa, Y., Kataoka, K., 2002. Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Deliv. Rev. 54, 203-222. (Pubitemid 34230442)
16. Kazuka, K., Hiraku, O., Yoshiharu, M., 1999. Biodisposition characteristics of N-succinyl-chitosan and glycol-chitosan in normal and tumor-bearing mice. Biol. Pharm. Bull. 22, 179-186.
17. Klockars, M., 1974. Distribution of lysozyme in the serum, urine and kidneys of AKR mice during the pathogenesis of lymphocytic leukemia. Acta Path. Microbiol. Scand. Sect. A 82, 665-674.
18. Lee., J.K., Lim, H.S., Jim, J.H., 2002. Cytotoxic activity of aminoderivatized cationic chitosan derivatives. Bioorg. Med. Chem. Lett. 12, 2949-2951. (Pubitemid 35266766)
19. Liu, Q.F., Ren, H.X., Zhang, J.G., Wei, Y.J., 2004. Study on the physical and chemical properties of low molecular N-trimethyl chitosan chloride and its effect on antitumor. Chin. J. Biochem. Pharm. 25, 218-220.
20. Megan, E.F., Francis, C.S., Jean, M.J.F., 2009. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc. Chem. Res. 42, 1141-1151.
21. Nam, H.Y., Kwon, S.M., Chung, H.J., Lee, S.Y., Kwon, S.H., Jeon, H.S., Kim, Y.Y., Park, J.H., Kim, J., Her, S.W., Oh, Y.K., Kwon, I.C., Kim, K.Y., Jeong, S.Y., 2009. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 135, 259-267.
22. Qin, C.Q., Du, Y.M., Xiao, L., Li, Z., Gao, X.H., 2002. Enzymic preparation of water-soluble chitosan and their antitumor activity. Int. J. Biol. Macromol. 31, 111-117. (Pubitemid 36143614)
23. Son, Y.J., Jang, J.S., Cho, Y.W., Chung, H., Park, R.W., Kwon, I.C., Kim, I.S., Park, J.Y., Seo, S.B., Park, C.R., Jeong, S.Y., 2003. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J. Control. Release 91, 135-145. (Pubitemid 37288884)
24. Sun, Z., Ma, Q.W., Zhao, T.D., Wei, Y.L., Wang, G.S., Li, J.S., 2000. Apoptosis induced by norcantharidin in human tumor cells. World. J. Gastroenterol. 6, 263-265. (Pubitemid 30223609)
25. Schmaljohann, D., 2006. Thermo- and pH-responsive polymers in drug delivery. Adv. Drug Deliv. Rev. 58, 1655-1670. (Pubitemid 44830149)
26. Samuels, R.J., 1981. Solid state characterization of the structure of chitosan films. J. Polym. Sci., B: Polym. Phys. 19, 1081-1105.
27. Tanaka, T., Kaneo, Y., Shiramoto, S., Iguchi, S., 1993. The disposition of serum proteins as drug-carriers in mice bearing Sarcoma 180. Biol. Pharm. Bull. 16, 1270-1275. (Pubitemid 24049994)
28. Wang, L.X., He, H.B., Tang, X., Shao, R.Y., Chen, D.W., 2006. A less irritant norcantharidin lipid microspheres: formulation and drug distribution. Int. J. Pharm. 323, 161-167.
29. Wang, Q., Zhang, L., Hu, W., Hu, Z.H., Bei, Y.Y., Xu, J.Y., Wang, W.J., Zhang, X.N., Zhang, Q., 2010. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomedicine 6, 371-381.
30. Wu, Y., Yang, W.L., Wang, C.C., Hu, J.H., Fu, S.K., 2005. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm. 295, 235-245. (Pubitemid 40558806)
31. Zeng, Q.B., Sun, M., 2009. Poly (lactide-co-glycolide) nanoparticles as carriers for norcantharidin. Mater. Sci. Eng. C 29, 708-713.